Possibilities and limitations of capillary electropherosis in pharmaceutical analysis.
Capillary electropherosis (CE) has been proved to be an important alternative to high-performance liquid chromatography (HPLC) in pharmaceutical analysis. However, when it comes to the analysis of compounds, e.g. impurities or metabolites, of very different polarity and water solubility CE and the related techniques come to its limits. This is demonstrated for the antipsychotic drug quetiapine and its impurities. A nonaqueous capillary electrophoresis (NACE) method was developed using a background electrolyte (BGE) composed of ammonium acetate dissolved in a mixture of acetonitrile and methanol including acetic acid to protonate the substances. The NACE method gave an excellent separation of all components. Since the conductivity of the BGE used in the NACE method is quite low and problems with current occurred, an additional aqueous capillary zone electrophoresis (CZE) method was developed for quetiapine and the two water soluble derivatives, using phosphate buffer as BGE. The method was validated with regard to repeatability and limit of detection.
Institute of Pharmacy and Food Chemistry, University of Würzburg, Germany.
C
C
Borst
F
F
Belal
U
U
Holzgrabe
D000143:Acids; D014150:Antipsychotic Agents / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D003987:Dibenzothiazepines / Q000032:analysis; D004340:Drug Contamination; D019075:Electrophoresis, Capillary / Q000379:methods*; D007202:Indicators and Reagents; D013058:Mass Spectrometry; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000032:analysis*; D000069348:Quetiapine Fumarate; D015203:Reproducibility of Results; D013237:Stereoisomerism; D013607:Tablets
D000143:Acids; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D007202:Indicators and Reagents; D004364:Pharmaceutical Preparations; D013607:Tablets; D000069348:Quetiapine Fumarate